Advances in Gene Editing via Clustered Regularly Interspaced Short Palindromic Repeats

doi:10.13560/j.cnki.biotech.bull.1985.2016-1085

Abstract

Abstract: CRISPR is a piece of clustered short-interspaced palindromic non-coding sequences,in which the invasive foreign DNA can be memorized by integrating new spacer sequences. However,Cas protein is responsible for supporting CRISPR transcription products---crRNA（CRISPR RNA）to splice foreign DNA. CRISPR-Cas system,based on the cooperation of the two segments,plays a role in resisting exogenous DNA infection. So far,CRISPR-Cas system attracts the attention from whole scientific community rapidly relying on its unique advantages,such as high efficiency,convenience,low cost and high specificity. This review summarizes the composition,structure and type of CRISPR-Cas system as well as the mechanism and advantages of CRISPR technology. Moreover,taking Streptococcus thermophilus as an example,the base arrangement and advanced structure of the CRISPR gene are also presented in order to provide references for the scientific research in molecular biology and related fields.

Key words: CRISPR-Cas system, gene editing, Streptococcus thermophilus, gRNA-Cas9 complex

HAO Meng-yuan, QU Xiao-jun, CUI Yan-hua. Advances in Gene Editing via Clustered Regularly Interspaced Short Palindromic Repeats[J]. Biotechnology Bulletin, 2017, 33(6): 45-53.

References

[1] Chylinski K, Makarova KS, Charpentier E, et al. Classification and evolution of type II CRISPR-Cas systems[J]. Nucleic Acids Research, 2014, 42（10）：6091-6105.
[2] 朱金洁. CRISPR-Cas9介导的玉米基因组定点编辑研究[D]：北京：中国农业大学, 2015.
[3] Jiang W, Bikard D, Cox D, et al. RNA-guided editing of bacterial genomes using CRISPR-Cas systems[J]. Nature Biotechnology, 2013, 31（3）：233-239.
[4] Nishimasu H, Ran FA, Hsu PD, et al. Crystal structure of Cas9 in complex with guide RNA and target DNA[J]. Cell, 2011, 156（5）：935-949.
[5] Chang N, Sun C, Gao L, et al. Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos[J]. Cell Research, 2013, 23（4）：465-472.
[6] Sturino JM, Joseph MS, Todd RK. Engineered bacteriophage-defence systems in bioprocessing[J]. Nature Reviews Microbiology, 2006, 4（5）：395-404.
[7] Abedon ST. Bacterial ‘immunity’ against bacteriophages[J]. Bacteriophage, 2012, 2（1）：50-54.
[8] 王立人. CRISPR/CAS系统介导的基因组大片段DNA编辑[D]：上海：华东师范大学, 2015.
[9] Bondy-Denomy J, Davidson AR. To acquire or resist：the complex biological effects of CRISPR-Cas systems[J]. Trends in Microbiology, 2014, 22（4）：218-225.
[10] Kunin V, Sorek R, Hugenholtz P. Evolutionary conservation of sequence and secondary structures in CRISPR repeats[J]. Genome Biology, 2007, 8（4）：61.
[11] van Embden JDA, van Gorkom T, Kremer K, et al. Genetic variation and evolutionary origin of the direct repeat locus of mycobacterium tuberculosis complex bacteria[J]. Journal of Bacteriology, 2000, 182（9）：2393-2401.
[12] Demay C, Liens B, Burguière T, et al. SITVITWEB-A publicly available international multimarker database for studying Mycobac-terium tuberculosis genetic diversity and molecular epidemiology[J]. Infection, Genetics and Evolution, 2012, 12（4）：755-766.
[13] Zanden AGMVD, Kremer K, Schouls LM, et al. Improvement of differentiation and interpretability of spoligotyping for mycobacterium tuberculosis complex isolates by introduction of new spacer oligonucleotides[J]. Journal of Clinical Microbiology, 2002, 40（12）：4628-4639.
[14] Lillestøl R, Redder P, Garrett RA, et al. A putative viral defence mechanism in archaeal cells[J]. Archaea, 2006, 2（1）：59-72.
[15] Choi KR, Sang YL. CRISPR technologies for bacterial systems：current achievements and future directions[J]. Biotechnology Advances, 2016, 34（7）：1180-1209.
[16] Li C, Cao W. Advances in CRISPR/Cas9-mediated gene editing[J]. Chinese Journal of Biotechnology, 2015, 31（11）：7080-7081.
[17] Makarova KS, Haft DH, Barrangou R, et al. Evolution and classification of the CRISPR-Cas systems[J]. Nature Reviews Microbiology, 2011, 9（6）：467-477.
[18] Makarova KS. Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems[J]. Biology Direct, 2011, 6（1）：38-38.
[19] Chylinski K, Le RA, Charpentier E. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems[J]. RNA Biology, 2013, 10（5）：726-737.
[20] Wei C, Liu J, Yu Z, et al. TALEN or Cas9 - rapid, efficient and specific choices for genome modifications[J]. Journal of Genetics and Genomics, 2013, 40（6）：281-289.
[21] Anantharaman V, Iyer LM, Aravind L. Presence of a classical RRM-fold palm domain in Thg1-type 3'-5' nucleic acid polymerases and the origin of the GGDEF and CRISPR polymerase domains[J]. Biology Direct, 2010, 5（1）：43.
[22] Nickel L, Weidenbach K, Jäger D, et al. Two CRISPR-Cas systems in Methanosarcina mazei strain Gö1 display common processing features despite belonging to different types I and III[J]. RNA Biology, 2013, 10（5）：779-791.
[23] Marraffini LA, Sontheimer EJ. CRISPR interference limits horizontal gene transfer in Staphylococci by targeting DNA[J]. Science, 2008, 322（322）：1843-1845.
[24] Hale CR, Majumdar S, Elmore J, et al. Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs[J]. Molecular Cell, 2012, 45 （3）：292-302.
[25] Makarova KS, Koonin EV. Annotation and classification of CRISPR-Cas systems[J]. Methods in Molecular Biology（Clifton, NJ）, 2015, 1311：47-75.
[26] Fujii W, Kakuta S, Yoshioka S, et al. Zygote-mediated generation of genome-modified mice using Streptococcus thermophilus 1 -derived CRISPR/Cas system[J]. Biochemical & Biophysical Research Communications, 2016, 477（3）：473-476.
[27] Wu Q, Tun HM, Leung FC, et al. Genomic insights into high exopolysaccharide-producing dairy starter bacterium Streptococcus thermophilus ASCC 1275[J]. Scientific Reports, 2014, 4（7500）：4974.
[28] Horvath P, Romero DA, Coûtémonvoisin AC, et al. Diversity, activity, and evolution of CRISPR loci in Streptococcus thermophilus[J]. Journal of Bacteriology, 2008, 190（4）：1401-1412.
[29] 邓凯波, 霍贵成. 嗜热链球菌中CRISPR序列的检测与同源性分析[J]. 食品科学, 2013, 34（3）：153-157.
[30] Bolotin A, Quinquis B, Sorokin A, et al. Clustered regularly interspaced short palindrome repeats（CRISPRs）have spacers of extrachromosomal origin[J]. Microbiology, 2005, 151（Pt 8）：2551-2561.
[31] Mojica FJ, Díezvillaseñor C, Garcíamartínez J, et al. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements[J]. Journal of Molecular Evolution, 2005, 60（2）：174-182.
[32] Goh YJ, Goin C, O’Flaherty S, et al. Specialized adaptation of a lactic acid bacterium to the milk environment：the comparative genomics of Streptococcus thermophilus LMD-9[J]. Microbial Cell Factories, 2011, 10 Suppl 1（1）：S22.
[33] Brouns SJ, Jore MM, Lundgren M, et al. Small CRISPR RNAs guide antiviral defense in prokaryotes[J]. Science, 2008, 321（5891）：960-964.
[34] Jinek M, Chylinski K, Fonfara I, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity[J]. Science, 2012, 337（6096）：81.
[35] Sapranauskas R, Gasiunas G, Fremaux C, et al. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli[J]. Nucleic Acids Research, 2011, 39（21）：9275-9282.
[36] Jinek M, Jiang F, Taylor DW, et al. Structures of Cas9 endonucle-ases reveal RNA-mediated conformational activation[J]. Science, 2014, 343（6176）：124799.
[37] Qi LS, Larson MH, Gilbert LA, et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression[J]. Cell, 2013, 152（5）：1173-1183.
[38] Mali P, Yang L, Esvelt KM, Aach J, Guell M, Dicarlo JE, Norville JE, Church GM. 2013. RNA-guided human genome engineering via Cas9. Science 339：823-826.
[39] Zhang L, Jia R, Palange NJ, et al. Large genomic fragment deletions and insertions in mouse using CRISPR/Cas9[J]. PLoS One, 2015, 10（3）：e0120396.
[40] Oh JH, van Pijkeren JP. CRISPR-Cas9-assisted recombineering in Lactobacillus reuteri. [J]. Nucleic Acids Research, 2014, 42（17）：e131.
[41] Yosef I, Goren MG, Edgar R, et al. Using the CRISPR-Cas system to positively select mutants in genes essential for its function[J]. Methods in Molecular Biology, 2015, 1311：233-250.
[42] Ding Q, Regan SN, Xia Y, et al. Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs[J]. Cell Stem Cell, 2013, 12（4）：393-394.
[43] Jinek M, East A, Cheng A, et al. RNA-programmed genome editing in human cells[J]. Elife, 2013, 2（2）：e00471.
[44] Pattanayak V, Lin S, Guilinger JP, et al. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity[J]. Nature Biotechnology, 2013, 31（9）：839-843.
[45] Sander JD, Joung JK. CRISPR-Cas systems for editing, regulating and targeting genomes[J]. Nature Biotechnology, 2014, 32（4）：347-355.
[46] Fu Y, Foden JA, Khayter C, et al. High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells[J]. NatureBiotechnology, 2013, 31（9）：822-826.
[47] Cho SW, Kim S, Kim Y, et al. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases[J]. Genome Research, 2014, 24（1）：377-389.
[48] Semenova E, Severinov K. Interference by clustered regularly interspaced short palindromic repeat（CRISPR）RNA is governed by a seed sequence[J]. Proceedings of the National Academy of Sciences of the United States of America, 2011, 108（25）：10098-10103.
[49] Cradick TJ, Fine EJ, Antico CJ, et al. CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity[J]. Nucleic Acids Research, 2013, 41（20）：9584-9592.
[50] Zhang F. CRISPR/Cas9 for genome editing：progress, implications and challenges[J]. Human Molecular Genetics, 2014, 24（R6）：40-48.
[51] Gupta RM, Musunuru K. Expanding the genetic editing tool kit：ZFNs, TALENs, and CRISPR-Cas9[J]. The Journal of Clinical Investigation, 2014, 124（10）：4154-4161.
[52] Shah SA, Shah SA, Erdmann S, et al. Protospacer recognition motifs：mixed identities and functional diversity[J]. RNA Biology, 2013, 10（5）：891-899.
[53] Guilinger JP, Thompson DB, Liu DR. Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification[J]. Nature Biotechnology, 2014, 32（6）：577-582.
[54] Tsai SQ, Wyvekens N, Khayter C, et al. Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing[J]. Nature Biotechnology, 2014, 32（6）：569-576.
[55] Chen S, Sanjana Neville E, Zheng K, et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis[J]. Cell, 2015, 160（6）：1246-1260.
[56] Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems[J]. Science, 2013, 339（6121）：819-823.